LILRB1 and neoplasm: Consistent with these results, Amira A. Barkal et al. demonstrated that concurrent intercepting of the MHC class I-LILRB1 signaling axis may fuel macrophages to eliminate tumor cells and indirectly promote the functions of other immune cells [87].